Hadasit Ltd.'s Double Lumen PCI Guiding Catheter Prototype Demonstrates to be the First Guiding Catheter to Successfully Enable Administration of Medicine Directly to the Coronary Artery Throughout the Course of a PCI

Published: Sep 03, 2008

EIN KEREM, Israel--(BUSINESS WIRE)--Hadasit, the technology transfer company of Hadassah Medical Organization, announced today the successful pre-clinical testing of a prototype of the Double Lumen PCI Guiding Catheter for use in the treatment of coronary artery disease. Unlike today’s conventional catheters, the Double Lumen PCI Guiding Catheter has two lumens rather than one. The second lumen allows for a continuous medication infusion to the coronary artery during percutaneous coronary intervention (PCI), the part of the procedure when the narrowed coronary artery is dilated.

Back to news